Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer

NCT05806060 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Triple-Negative Breast Cancer

Interventions

DRUG: VEGFR and TPC
DRUG: TPC

Sponsor

Fudan University